Edinburgh-based charity the Global Alliance for Livestock Veterinary Medicines (GALVmed) has announced three drug discovery contracts in an effort to combat animal African Trypanosomosis (AAT), a disease which is estimated to cost Africa US$5billion a year.
Animal African trypanosomosis, transmitted by the tsetse fly, is a parasitic disease which affects livestock, resulting in a chronic illness which often ends in death. An estimated 50 million cattle and 70 million sheep and goats are at risk, with around 3 million cattle dying annually from the disease.
AAT causes economic losses in livestock, reducing meat and milk production and leaving animals so weak they are unable to help cultivate land. It affects over 10 million square kilometres of fertile land spread across nearly 40 countries in Africa and therefore has a huge impact on food and nutritional security and livelihoods across the continent.
The drugs that are currently used were developed in the 1950s and 60s and drug resistance is now a commonly reported problem. With few other options available, these drugs are the most important method of controlling the disease.
In May 2011 the Department for International Development (DfID) awarded GALVmed 30 month grant for £8million to facilitate the development of drugs, diagnostics and potential vaccines for the control of AAT.
The first contract was awarded to Anacor Pharmaceuticals Inc., a California based biopharmaceutical company established in 2002.
As part of a Drugs for Neglected Diseases Initiative (DNDi) supported project, Anacor and their partners discovered a series of compounds to combat the human form of AAT, Human African Trysanosomsis (HAT). A number of compounds produced under this programme have properties which could make them suitable for the treatment and prevention of animal AAT. These relevant compounds will now be screened for efficacy and safety under the GALVmed contract.
The second and third contracts have both been awarded to the College of Life Sciences at the University of Dundee, one of Europe's top-ranked universities for life science research.
Dr Kevin Read, who is Head of Drug Metabolism and Pharmokinectics at the drug Discovery Unit is leading a piece of drug discovery and development research, which aims to develop new drugs for the treatment and possible prevention of AAT in cattle, and also a diagnostic test for use in the field. This builds on the university's work on HAT and drugs that were unsuitable for human treatment are now being re-evaluated as potential drugs for cattle.
Dr Read said: "I am very excited to be working in partnership with GALVmed to apply our extensive drug discovery expertise in HAT to identify and bring forward new potential drugs for the treatment and prevention of AAT. The new project offers an exciting opportunity to reposition compounds showing great promise for the treatment of first stage HAT into AAT, thus improving food security in some of the poorest countries in sub-Saharan Africa."
The Suckler Herd Performance Checklist is designed to help veterinary surgeons and farmers work together to draw up a workable action plan to address the main areas influencing optimum herd health and performance.
The new app works on tablet computers, as well as Apple and Android smartphones, and allows vets to e-mail audit results directly to farmer clients following an interactive on-farm assessment.
MSD Animal Health’s beef and youngstock marketing manager Robert Simpson said: “This additional engagement tool helps a vet assess performance across the five crucial time periods and processes impacting on the efficiency of beef suckler herds.
“For example, reducing calf morbidity and mortality rates in a suckler herd starts with management practices before conception.
"Optimum performance also requires following proper management protocols throughout the youngstock period from birth to weaning, including effective colostrum administration, vaccination, nutrition and hygiene.
“It can also be used to provide confidence to vets who are less experienced with suckler herds, allowing them to follow a structured evidence-based approach when on farm,” he said.
Participants travel around South Africa working on game reserves, commercial farms and in poor communities, getting experience of game capture, providing veterinary care in townships and rural areas, working in a private clinic and handling and treating large farm animals.
There are also a range of weekend activities, including kayaking, quad biking, game drives, horse riding, surfing, beach walking, bars and restaurants.
Kim said: “We’ve designed the programme so that it’s suitable for people with a wide range of experience, including veterinary and veterinary nursing students, young people considering a career in the veterinary profession and animal lovers.”
For more information, visit: wildinsideadventures.com
Protek Biochem Ltd., a company set up by champion horse-rider Debbie Topping, has won the rights to sell Envirocair Veterinary, a new range of disinfectants and sanitisers targeted at dogs, cats and other domestic pets, as well as horses and farm animals.
The product is claimed to kill 99.99% of all viral, bacterial and fungal infections, and lasts for 14 days.
Debbie said: "I did not consider myself a businesswoman, just a normal horse-rider and animal lover. However, I was so impressed when I tried Envirocair Veterinary that, when I was offered the opportunity to become the main UK distributor, I jumped at the chance."
According to the company, the product is being used by a number of the horses and trainers heading to the London Olympics in 2012. It is now being rolled out across the rest of the UK's animal care sector.
Debbie says that veterinary surgeons, farmers, dog kennels, animal rescue centres, breeders and others will all be able to benefit from the new product: "Envirocair Veterinary doesn't harm skin or irritate the respiratory tract, so you don't need to get dressed up in special clothing every time you use it.
"Used properly, it quite literally kills the threat of major animal diseases such as parvovirus in dogs, which can otherwise be fatal in less than 72 hours.
"It's not an exaggeration to say that Envirocair will protect the health and even save the lives of countless numbers of animals across the UK."
Debbie signed the distribution agreement with the manufacturer Biotech International Ltd last month, before officially launching Envirocair Veterinary this week.
For more information on Protek Biochem Ltd or Envirocair Veterinary, visit http://www.protekbiochem.com/.
Horiba Medical has announced it is the official exclusive UK distributor of the fully automated Vet abc Plus+ veterinary haematology analyser from scil animal care company GmbH, Germany.
According to the company, the compact Vet abc Plus+ provides a complete blood count (CBC), including 4-part white blood cell (WBC) differential, from only 10 µl of EDTA whole blood, in only 60 seconds.
The Vet abc Plus+ provides pre-installed settings to analyse samples from dogs, cats, horses, rabbits, mice, rats, cattle, pigs and sheep. For dogs, cats and horses, the Vet abc Plus+ provides a 4-part WBC differential blood count, including a differentiation of the leucocytes to identify lymphocytes, monocytes, granulocytes and eosinophils. Results are available in 60 seconds on screen or can be automatically printed out and transferred to the practice information system or clinical notes. For ease-of-use, the Vet abc Plus+ also incorporates a self-contained reagent and waste system which provides a clean operation whilst being easy to replenish.
Borne from an existing manufacturing partnership, scil and HORIBA Medical already have over 6000 veterinary haematology analysers placed globally. Horiba says the new UK distribution agreement enables UK veterinary professionals to not only procure the Vet abc Plus+ analyser, but also receive expert service and support directly from the manufacturer HORIBA Medical and its team of UK specialists.
For more information, visit: www.horiba.com/uk/medical
Mike Gooding, chairman of organiser RAFT Solutions said: “High precision methods are critical to the future of UK livestock farms and their vets.
“The event offers an A-list of international speakers to explain the opportunities presented by precision management techniques that can be applied in practice to any livestock enterprise.”
One example is early detection of sub-optimal animal performance and timely intervention, which is included in the session: ‘Big Tech and what it offers Precision Livestock Farming’.
The session will explore the use of data to empower precision decisions with Prof Jasmeet Kaler from University of Nottingham.
There will also be an open debate about consumer perceptions, legislative governance, and impacts upon or opportunities for farmers and vets.
Mike added: "All conference-goers, whether attending in person or on-line, will be challenged to adapt their thinking and focus on post-conference changes for the better."
A choice of one- or two-day tickets is available at connectmyevent.com/raftsolutionsltd/plfip2021.
Themed 'Controlling Disease Threats at Home and from Abroad’, this year's conference will highlight the increasing importance of OVs in safeguarding the UK’s international trade and in protecting human health through disease surveillance and control.
The conference programme includes dedicated lecture streams aimed at large animal, small animal and equine practitioners. Improve says that lecture content has been tailored to cover areas of key relevance for more than 8,000 OVs due to revalidate their qualifications in March 2019. The programme also includes interactive workshops, including drop-in question and answer sessions offering practical advice and guidance on the revalidation process.
An exhibition of products and services for OVs runs alongside the conference.
David Babington MRCVS, Business Development Director at Improve, said: "This conference remains the only event dedicated to the needs of OVs. They receive industry updates from leading figures in the veterinary sector, attend lectures on OV work from experts and, in so doing, work towards their CPD revalidation requirements. We’re currently finalising a packed programme for this year’s conference and urge OVs to take advantage of our time-limited Early Bird offers and register without delay."
For more information on the Official Veterinarian Conference and Exhibition or to register visit: www.officialvet.com
The company says Euthoxin 500mg/ml is a stronger dose than any other pentobarbital injection products currently available on the UK and Irish markets which means less volume per dose and a better return for veterinary surgeons.
Gareth Carr, commercial manager for Chanelle Vet UK, said: "Our aim is to support UK vets by offering high-quality products at competitive prices.
"We have developed Euthoxin with the veterinarian in mind to offer them a cost-effective, low-volume, reliable euthanasia for a wide spectrum of species."
Euthoxin 500 mg/ml launches officially on 3rd July and will be available from wholesale partners in vials of 100ml.
For further information, download the SPC here, visit www.chanellegroup.co.uk or contact your key account manager for information about a launch offer.
Zoetis has announced that Suvaxyn MH-One, its vaccine against Mycoplasma hyopneumoniae in pigs, has a revised licence allowing it to be administered from seven days of age with a two-week onset of immunity.
The company says this means that piglets can be protected by three weeks of age when they are commonly already infected with M. hyo. Duration of immunity extends well beyond the average UK pig slaughter age of 176 days.
Nigel Lodge, National Veterinary Manager for Zoetis in the UK said: "This is a significant step forward, recognising the full efficacy of the Suvaxyn MH-One vaccine against enzootic pneumonia. Trials have confirmed that use of Suvaxyn MH-One at seven days reduces lung lesions - even in the presence of maternally derived antibodies.
"The vaccine, which adds to our large and growing pig vaccine and product portfolio, also benefits from using adjuvants carbopol and squalane."
According to the company, the performance gains from early protection are shown in a field trial with 240 pigs injected at one week of age which showed significantly higher average daily weight gain, providing nearly 5 kg extra weight over the study period to 166 days.
Defra's Chief Veterinary Officer's annual report was published this week, reviewing developments in animal health and welfare during 2007.
The report, by former Chief Veterinary Officer (CVO) Fred Landeg, summarises progress and developments in the field of animal health and welfare within Great Britain. It also provides a continuous statistical record of the state of animal disease in Great Britain.
Topics covered in the 2007 report include the outbreaks of Foot and Mouth Disease, Avian Flu and Bluetongue, and progress on the UK's Responsibility and Cost Sharing Programme.
Other major areas covered in the report are:
A copy of the full report can be found at http://defraweb/animalh/cvo/report.htm
The European Commission has announced the EU's animal health strategy for 2007-13. The announcement provides the framework for animal health measures over the next 6 years, taking into account feedback from stakeholders and potential challenges in the future.
The overall aim is to put greater focus on precautionary measures, disease surveillance, controls and research, in order to reduce the incidence of animal disease and minimise the impact of outbreaks when they occur. Click here for more ...
The Dairy Vet of the Year award, which is organised by the British Dairying Magazine and sponsored by Krka UK Ltd, recognises a veterinary surgeon for going the extra mile in helping to create a more positive, forward-thinking dairy industry.
In addition to her work as a farm vet, Sarah is also Technical Director at the TB Advisory Service (TBAS), which involves her overseeing and delivering training for new advisors, chairing technical board meetings and delivering farmer meetings across the country. She also provides bespoke advice to farmers in High Risk and Edge Areas of England, and is known for her compassion and understanding for those suffering a TB breakdown.
She is also a member of the TB Eradication and Advisory Group (TBEAG) for England, which advises government policy makers on all aspects of TB control in England.
Lindsay Heasman, Project Manager at TBAS, said: “Sarah is an authority on TB and understands the responsibility that comes with this role. She uses her position for good at all times and is prepared to make statements that are not always universally popular. By standing by her beliefs and dispelling misconceptions, she has won the respect of farmers across the country. Her dedication has, at times, come at personal cost, but her passion for eradicating bTB and support for farmers in achieving this goal never wavers.”
Sarah said: “I am just a farm vet doing the same job every farm vet does daily across the country. Through necessity, seeing my clients being devastated by TB breakdowns every day, I felt passionate about doing something about it. TBAS, my colleagues I am lucky to work with, and TBEAG have given me the platform to do this. I am very humbled that the judges though me worthy of the Award amongst the other hard-working vets."
Photo: Giles Brandreth, Charlotte Read, Sarah Tomlinson and Sean Sparling
There are three awards on offer: two ruminant bursaries and one companion animal bursary. Applications must be in by 30th November 2018.
Each project should be completed within one to two years and the vet practitioner proposals will be judged by university academics to ensure independent assessment.
The companion animal research bursary will be assessed by the University of Nottingham Centre for Evidence-based Veterinary Medicine and the ruminant research bursary applications will be assessed by academic staff from the University of Bristol School of Veterinary Science.
Michelle Townley, veterinary advisor at MSD Animal Health (pictured right) said: "New knowledge and good research skills form the lifeblood of the industry so we’re keen to get as many applications as possible as part of our commitment to encouraging research in the veterinary industry."
For further details go to the MSD Animal Health Research Bursary website: www.msdahresearchbursary.co.uk.
The webinar, which will be streamed live at 8pm on Wednesday 20th November and will be available to watch for six months thereafter, is being presented by James Husband, an RCVS Specialist in cattle health & production.
Topics will include oxidative stress, its impact on cattle performance and the role of trace minerals in immunity and cattle health. The webinar will also cover the current complexities of oral supplementation including absorption and mineral antagonism, along with offering information about the latest innovation to boost trace mineral availability during high demand periods in the production and breeding life cycle.
To register for the webinar, visit: https://www.thewebinarvet.com/pages/register-free-role-trace-minerals-cattle-health-performance-new-veterinary-approach-boost-trace-mineral-availability/
All vets who view the webinar, either live or as a recording on the website, will be able to download a CPD certificate.
The Welsh Government Deputy Minister for Farming and Food, Rebecca Evans, has officially opened the new Wales Veterinary Science Centre.
The centre, which is located on the site of the former Animal and Plant Health Agency's (APHA) Veterinary Investigation Centre, has been established by Iechyd Da, a consortium of independent veterinary practices based in Wales together with Welsh Lamb and Beef Producers Ltd, and Aberystwyth University.
Iechyd Da was recently appointed by APHA as a third party provider to deliver expert post-mortem examinations of new and re-emerging diseases of farm animals. The service has been operational since April 2015.
Deputy Minister Rebecca Evans AM said: "I am pleased to officially open the Wales Veterinary Science Centre, which will significantly strengthen and enhance the important contribution the veterinary profession makes to rural life in Wales and raises standards of animal health and welfare. It will also bolster the rural economy by securing technical jobs for the area, benefit the wider economy by supporting our farming communities, and be an asset to the UK by contributing valuable data to the surveillance network."
Professor Christianne Glossop, Chief Veterinary Officer for Wales said: "The Centre will have a significant role in the protection of animals in Wales and will provide an important contribution to a successful and resilient farming industry, reflecting the essential role of the veterinary profession in Wales."
Phil Thomas, Director of Iechyd Da said: "Iechyd Da now looks forward to building on the post-mortem provision already available so that we can provide a range of services, from running training courses for animal keepers to dissection classes for students, continuous professional development for practicing vets, and supporting disease eradication schemes. The vision is of a One Health institute that recognises the interlocking, overlapping relationships between people, livestock, the wildlife and the environment around us."
Richard Irvine, Head of Scanning Surveillance and the Surveillance Intelligence Unit at the Animal and Plant Health Agency (APHA) said: "I look forward to APHA working in close partnership with the Wales Veterinary Science Centre to provide expert diagnostic support and surveillance intelligence for veterinary practices and farmers in Wales. Only by working together can we create an effective disease surveillance network, and I urge farmers and vets in Wales to make use of the considerable expertise that exists within the Wales Veterinary Science Centre and APHA."
MSD Animal Health has announced the launch of Cepralock, a new teat sealant to complement its dry cow intramammary product Cepravin Dry Cow and wider Dairy Herd Health portfolio.
The company says the new product is designed for use at drying off, with or without a dry cow intramammary antibiotic, and provides an important inert barrier in the teat canal to reduce significantly the risk of bacterial infection of the udder during the dry period.
Cepralock is supplied in tubes with the option of short nozzles that are designed to help avoid the risk of teat damage and incorrect administration beyond the teat canal.
The launch is also being accompanied by dry cow therapy training and a support programme for veterinary practitioners and their dairy farmer clients. This will include diagnostics and data analytics, and training will have a significant focus on correct administration and removal of teat sealant after calving, allowing vets to provide adequate reassurances to their clients around product use.
MSD Animal Health technical adviser Martin Behr said: "The dry period is a critical time for vets as they seek to help their clients in the battle to combat mastitis, which remains a significant drain on dairy herd profitability. It provides an ideal opportunity to clear up existing bacterial infections in the udder with the use of intramammary antibiotics, but it is also vital to prevent new infections over the period.
"Cows do have their own natural physical defence against infection in the form of the keratin plug that forms in the teat canal after drying off, but this is not always sufficiently effective. In a recent study it was shown that only 50% of 500 examined quarters had a fully developed keratin plug within 10 days of drying off, whilst 20% of teats remained open into the second half of the dry period. This is significant because the majority of clinical cases of mastitis that occur during the dry period do so within the first three weeks.
"Correct use of a teat sealant at drying off, immediately after the administration of the dry cow intramammary if used, will provide an effective physical barrier for the duration of the dry period, significantly reducing the chances of new infections of the udder."
According to MSD, it is estimated that less than half of dairy cows are currently given a teat sealant at drying off, despite the concept being established for a number of years and numerous farm studies providing strong evidence of their efficacy.
Martin added: "The potential return on investment for dairy farmers of correctly applied teat sealants is clear. A single case of mastitis is estimated to cost between £70 and £250 and the average UK dairy herd suffers somewhere in the region of 50 to 60 cases per 100 cows per lactation. A correctly applied dry cow therapy programme, including the use of teat sealants, will significantly reduce the incidence of clinical mastitis, thereby providing a demonstrable return on investment.
"At MSD Animal Health we are keen to help veterinary practitioners promote best practice in dry cow therapy, including the adoption of the correct protocols and application procedures. Therefore we are supporting the launch of Cepralock with the offer of Continuous Professional Development for veterinary practitioners on all aspects of dry cow therapy, including correct use of teat sealant and its removal after calving."
Cepralock teat sealant is available to veterinary practices in packs of 24 tubes and 120 tubes.
For more information about Cepralock or MSD's Dry Cow Management Support package for vets and farmers, contact your Account Manager.
Intervet/Schering-Plough Animal Health has announced that Metricure is now back in stock and available from the veterinary wholesalers with immediate effect.
Metricure is the only licensed intra-uterine antibiotic for the treatment of endometritis and is specially designed for the anaerobic intra-uterine environment.
The company would like to thank the profession for its patience and understanding, and looks forward to supporting vets striving to improve fertility on clients' farms.
Please contact the Intervet/Schering-Plough Veterinary Support Group on 01908 685685 if you require any further information.
Gabbrovet Multi is the first and only ready-to-use solution licensed to treat both cryptosporidium and E.coli diarrhoea in calves.
The company highlights a study of 334 calves with severe diarrhoea, where those receiving Gabbrovet Multi showed a faster and more effective response than those given halofuginone1.
Harry Walby, ruminant veterinary advisor at Ceva Animal Health, said: “Gabbrovet Multi is the first and only ready-to-use solution for the convenient treatment of both cryptosporidium and E.coli, two of the most common causes of neonatal scour in calves."
Gabbrovet Multi can be administered in milk or water.
It is available with a dosing cap and comes in 250ml, 500ml or 1l presentations.
Gabbrovet Multi also treats gastro-intestinal infections caused by E.coli in pigs.
For further information, contact your local Ceva Animal Health territory manager or email cevauk@ceva.com.
References
Life Technologies has announced the launch of a new ELISA test for bluetongue virus (BTV) antibodies.
According to the company, studies have confirmed that the LSI VET Ruminant Bluetongue II-serum ELISA can detect antibodies to BTV in experimentally infected sheep after 6 days, and in cattle after 7-8 days - several days sooner than some other commercially available test kits, including the company's previous ELISA test which the new product has replaced.
Life Technologies asked the UK's Pirbright Institute, the European Union Reference Laboratory for BTV, to conduct a preliminary assessment of the new test. The new test was able to detect antibodies in all 24 BTV reference sera and BTV 26 held by Pirbright, and showed high sensitivity in a longitudinal study of experimentally infected animals.
The Pirbright study also demonstrated that the LSI VET Ruminant Bluetongue II-serum ELISA could detect BTV antibodies in cattle and sheep that had been vaccinated with an inactivated Bluetongue vaccine.
The new test was developed by Life Technologies Animal Health in its research laboratory near Lyon in France and will be available in EU countries via Life Technologies Animal Health distributors according to local regulatory requirements (see www.lifetechnologies.com/lsi-animal-health) for details.
To meet market demands and ensure that their customers comply with regulatory requirements, British manufacturer Labcold has released the first models in a new range of vaccine and pharmaceutical refrigerators designed specifically for this use from the ground-up. The company says more models will be added to the range over the next 12 months.
When storing temperature-sensitive vaccines and pharmaceuticals, Veterinary Practices need to ensure compliance with an ever-increasing burden of legislation, regulations and guidelines, such as the latest VMD Code of Practice, (Oct 2007). The BVA Good Practice Guide - Standard Operating Procedure 04 on the storage of medicinal products in permanent premises says as follows:
Refrigerated storage must:
Although this guidance stops short of specifically excluding the use of domestic refrigerators, Labcold says professional products are more appropriate since they are built specifically for vaccine and pharmaceutical storage. Labcold refrigerators all fully compliant and have locking doors plus a host of handy options including capacity, glass doors and a new divided-drawer system.
Robin Gregson, Sales & Marketing Director at Labcold said, "Our whole product range is constantly being updated to ensure that we provide our customers with market-leading solutions. Many previous pharmacy refrigerators have simply been modified designs of domestic fridges, whilst our new range, the result of three years work, is one of the few on the market to be designed specifically for pharmacy use from the ground up."
For full information on all Labcold products, including portable refrigerators suitable for farm vets please visit http://www.labcold.com/ or contact sales@labcold.com / Telephone 0870 3001001 for a free copy of the latest Product Guide.
Evidence-Based Veterinary Medicine Matters: Our Commitment to the Future represents the first time that such a broad and influential group has united in support of a single issue in the veterinary profession.
The publication contains a number of case studies which illustrate the impact that evidence can have – and has had – on animal health and welfare. It also provides a rationale for veterinary professionals to contribute to the evidence base and put evidence into practice, to the benefit of animals, owners and veterinary teams themselves.
The signatories to the commitment are:
Animal and Plant Health Agency
British Cattle Veterinary Association
British Equine Veterinary Association
British Small Animal Veterinary Association
British Veterinary Association
British Veterinary Nursing Association
RCVS Knowledge
Royal College of Veterinary Surgeons (RCVS)
Royal Veterinary College
University of Bristol
University of Cambridge
University of Liverpool
University of Nottingham
University of Surrey
Veterinary Policy Research Foundation
No sign of the BAHVS, I see.
Jacqui Molyneux, Chair of the Board of Trustees of RCVS Knowledge, said: "Evidence-Based Veterinary Medicine Matters is a milestone publication for the professions, representing the first time the majority of the key institutions have aligned under the same EBVM banner.
"A celebration of decades of incredible discoveries, achievements and improvements in animal health, it also serves to remind us that even the earliest forms of veterinary medicine were underpinned by evidence."
UK Chief Vet Christine Middlemiss said: "What’s the evidence? An evidence-based approach is vital in all areas of our profession, whatever is keeping you awake at night. For me, it is the threat of African swine fever and avian flu. The evidence I rely on comes from our specialist surveillance monitoring and testing, veterinary epidemiologists and disease modellers. It enables me to make timely, proportionate risk-based decisions that stand up to scrutiny.
"If you are managing veterinary care in practice, the evidence you rely on to underpin your standards of clinical care comes from multiple sources too. Evidence-based veterinary medicine allows us to refine and tailor strategies to be effective and efficient, making full use of existing and new technologies.
"The profession has taken great strides towards embracing evidence-based veterinary medicine and building on this will strengthen the links between clinical decision-making, policy development and future research."
Chris Gush, Executive Director of RCVS Knowledge, added: "We are impressed by the contributions from our co-signatories, which clearly demonstrate the phenomenal impact on patient outcomes that conducting research and using evidence can have. We are also delighted that Sense about Science, a flagbearer for evidence, transparency and rational thinking, has joined with us to highlight the many benefits EBVM can bring.
"The publication also makes a strong case for much-needed funding for research to grow the evidence base, which would put powerful, robust data into the hands of veterinary professionals as they make critical decisions that can affect patient outcomes.
"It is our hope that the calibre, diversity and sheer number of the organisations putting their name to this commitment will galvanise all vets and their teams to expand their use of evidence in practice."
Rebecca Asher, Deputy Director at Sense about Science, said: "This is a showcase of game changers in veterinary care and we hope it will inspire and motivate everyone in the profession.
"We were delighted that RCVS Knowledge approached us to collaborate with them and other leading institutions in the veterinary research community to affirm their commitment to an evidence-based approach to veterinary medicine.
"Everyone expects treatment for humans to be underpinned by evidence. We now expect the same of the whole veterinary community when it comes to the treatment of animals."
The full commitment and portfolio of case studies can be read in Evidence-Based Veterinary Medicine Matters, available for free online: bit.ly/EBVMMatters.
The company says that the effervescent tablet presentation was designed to significantly improve vaccination practices for poultry producers while maintaining reliable virus protection.
Boehringer says this dispensing form reduces the risk of stock solution contamination and, when compared to glass vials, the small blister packs make vaccine management safer for operators, take up less room in the fridge and reduce packaging waste by 90%.
HatchPak IB H120 NeO will be available shortly in packs of 10 tablets of 1000 doses or 10 tablets of 2000 doses.
Callum Blair, Boehringer Ingelheim Avian and Swine Brand Manager, said: "The addition of HatchPak IB H120 NeO to our NeO product portfolio is evidence of our continued investment in the poultry sector."
The move comes as the whole agriculture industry, co-ordinated by agricultural and food industry alliance RUMA (which promotes responsible use of medicines in farming), looks to build on the recent 10% reduction in use of antibiotics to treat farm animals.
The BCVA’s Dr Elizabeth Berry, who prepared the recommendations, said that whilst the responsible use of antibiotics has been promoted for many years across farming sectors, there is still the potential to reduce use in some areas and to move away from products which are important for human health.
She said: "This is an official position from BCVA to our members but we would like to see all in the cattle sectors embrace these recommendations in the understanding that we need to play our part in increasing responsible use of antibiotics.
"Work still needs to be done to establish the levels currently being used in cattle so that appropriate targets can be set but there are measures that can immediately be adopted.
"So we are recommending reducing both the overall amount of antibiotics used in cattle practice and minimising the use of the high priority CIAs – namely third and fourth generation cephalosporins, fluoroquinolones and colistin. These drugs should only be used where they have been demonstrated by sensitivity testing to be the only suitable choice to avoid unnecessary suffering."
The BCVA, which has over 1,100 practising members covering around 85% of vets working with cattle, is also recommending that use of antibiotics as a preventative treatment is avoided wherever possible as long as animal welfare is not compromised.
Dr Berry added: "Where preventative treatment – or prophylaxis – is used it should be regarded as an interim measure whilst alternative management or vaccination strategies are implemented.
"For example, all cows which comply with recommendations for using an internal teat sealant should be considered for non-antibiotic treatments at drying off."
The BCVA continues to advise that every farm should have a herd health plan which embraces all of the disease control strategies appropriate for disease reduction on that farm. In addition, farm management best practice should be followed, such as the guidelines issued by Red Tractor farm assurance.
Dr Berry says BCVA further recommends that all herds should establish their BVD status and eradicate the disease where it is found. "BVD can have a detrimental effect on incidence of many diseases and its eradication will have a significant impact on the need for antimicrobial use.
"We also continue to recommend the use of diagnostics to identify disease so that appropriate treatments can be selected and vaccination programmes instituted to prevent or reduce the severity of disease."
BCVA’s confirmation of its official position has been welcomed by RUMA. Secretary General John FitzGerald says that while RUMA’s promotion of responsible use over the past 20 years means the UK remains among the lower users of antibiotics in farming in Europe1, more needs to be done.
"The BCVA’s position is clear and leaves no doubt that action needs to be taken,” says Mr FitzGerald. “It is underpinned by science, recognising that banning preventative use outright or access to critically important antibiotics is not an answer. Both are important tools in fighting disease and preventing suffering so we still need them – but we need to use them more strategically and only when no other options exist."
The complete list of guidelines can be downloaded from the BCVA website www.bcva.eu.